Summary: SUNHO BIO-B (02898) reported Operating profit of -79.05M(+40.12%); Net profit attributable to owners of -79.97M(+39.74%).
ReportedYoY
Prior YearYoY
Operating profitUp YoY
-79.05M40.12%
-132.01M181.39%
Net profit attributable to ownersUp YoY
-79.97M39.74%
-132.70M155.25%
Operating profit
Reported
Net profit attributable to owners
Reported
ROEYoY
FY 2021
FY 2022
FY 2023
FY 2024
Profitability
(YoY)
Growth
(YoY)
Asset Quality
(YoY)
Cash Generation
(YoY)
Other income and gainsYoY
FY 2021
FY 2022
FY 2023
FY 2024
Revenue
(YoY)
Expenses
(YoY)
Interest
(YoY)
Profit
(YoY)
Cash and cash equivalentsYoY
FY 2021
FY 2022
FY 2023
FY 2024
Assets
(YoY)
Liabilities
(YoY)
Equity
(YoY)
Net cash from operating activitiesYoY
FY 2021
FY 2022
FY 2023
FY 2024
Operating Cash Flow
(YoY)
Investing Cash Flow
(YoY)
Financing Cash Flow
(YoY)
Net Change in Cash
(YoY)
Financial data: HKEXnews annual and interim reports; pre-listing years from the prospectus. YoY for ratios is the change in percentage points; ROE and ROA use annual reports only.
About this page
This page shows SUNHO BIO-B (02898) historical financial statements and corporate actions. Financial data comes from public financial disclosures in HKEX display documents, grouped by reporting period; corporate actions come from HKEXnews announcements.